{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:06:01Z","timestamp":1761901561977,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T00:00:00Z","timestamp":1591488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.msard.2020.102265","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T11:21:00Z","timestamp":1591442460000},"page":"102265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The relationship between aquaporin-4 antibody status and visual tract integrity in neuromyelitis optica spectrum disorders: A visual evoked potential study"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9668-6446","authenticated-orcid":false,"given":"Krzysztof","family":"Bar\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystyna","family":"Gospodarczyk-Szot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Nojszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Podlecka-Pi\u0119towska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Zakrzewska-Pniewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.msard.2020.102265_bib0001","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2012.07.014","article-title":"Diagnostic utility of NMO\/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients","volume":"320","author":"Apiwattanakul","year":"2012","journal-title":"J. Neurol. Sci."},{"issue":"18","key":"10.1016\/j.msard.2020.102265_bib0002","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2020.102265_bib0003","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1212\/NXI.0000000000000580","article-title":"Neuromyelitis optica spectrum disorder: patient experience and quality of life","volume":"6","author":"Beekman","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.msard.2020.102265_bib0004","doi-asserted-by":"crossref","first-page":"678\u2010688","DOI":"10.1177\/1352458514567216","article-title":"Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography","volume":"21","author":"Bennett","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2020.102265_bib0005","article-title":"The clinical profile of NMOSD in Australia and New Zealand [published online ahead of print, 2020 Jan 31]","author":"Bukhari","year":"2020","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2020.102265_bib0007","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1177\/1352458511431727","article-title":"Comparison of clinical, immunological and neuroimaging features between anti-aquaporin-4 antibody-positive and antibody-negative Sjogren's syndrome patients with central nervous system manifestations","volume":"18","author":"Estiasari","year":"2012","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2020.102265_bib0008","doi-asserted-by":"crossref","first-page":"605\u2010624","DOI":"10.1002\/ana.24608","article-title":"Clinicopathological features in anterior visual pathway in neuromyelitis optica","volume":"79","author":"Hokari","year":"2016","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2020.102265_bib0009","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","article-title":"Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica","volume":"4","author":"Jarius","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.msard.2020.102265_bib0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.msard.2020.102265_bib0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2020.102265_bib0012","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.msard.2020.102265_bib0013","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/1352458507085758","article-title":"Multimodal evoked potentials measure and predict disability progression in early relapsing\u2013remitting multiple sclerosis","volume":"14","author":"Jung","year":"2008","journal-title":"Mult. Scler. J."},{"issue":"2","key":"10.1016\/j.msard.2020.102265_bib0014","doi-asserted-by":"crossref","first-page":"137\u2010145","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica","volume":"88","author":"Kawachi","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.msard.2020.102265_bib0015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2020.102265_bib0017","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.msard.2020.102265_bib0018","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/0929866524666170110150436","article-title":"Role of AQP4 antibody serostatus and its prediction of visual outcome in neuromyelitis optica: a systematic review and meta-analysis","volume":"24","author":"Lin","year":"2017","journal-title":"Protein Pept. Lett."},{"issue":"2","key":"10.1016\/j.msard.2020.102265_bib0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1017\/S0317167100013287","article-title":"Serum-positive and -negative AQP4 antibody NMO in Chinese patients","volume":"39","author":"Long","year":"2012","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.msard.2020.102265_bib0021","doi-asserted-by":"crossref","first-page":"e10455","DOI":"10.1371\/journal.pone.0010455","article-title":"Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica","volume":"5","author":"Mader","year":"2010","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.msard.2020.102265_bib0022","doi-asserted-by":"crossref","first-page":"362\u2010371","DOI":"10.1097\/WCO.0000000000000813","article-title":"Novel insights into pathophysiology and therapeutic possibilities reveal further differences between AQP4-IgG- and MOG-IgG-associated diseases","volume":"33","author":"Mader","year":"2020","journal-title":"Curr. Opin. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2020.102265_bib0023","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s10384-018-0607-4","article-title":"Visual function and inner retinal structure correlations in aquaporin-4 antibody-positive optic neuritis","volume":"62","author":"Mekhasingharak","year":"2018","journal-title":"Jpn. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.msard.2020.102265_bib0049","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1212\/NXI.0000000000000204","article-title":"Serum Peptide Reactivities May Distinguish Neuromyelitis Optica Subgroups and Multiple Sclerosis","volume":"3","author":"Metz","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.msard.2020.102265_bib0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.msard.2018.07.025","article-title":"MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder","volume":"25","author":"Narayan","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2020.102265_bib0026","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/1352458512447597","article-title":"Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica","volume":"19","author":"Neto","year":"2013","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2020.102265_bib0027","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1212\/NXI.0000000000000334","article-title":"Microstructural visual system changes in AQP4-antibody-seropositive NMOSD","volume":"4","author":"Oertel","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2020.102265_bib0028","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2016.02.060","article-title":"Evoked potentials are useful for diagnosis of neuromyelitis optica spectrum disorder","volume":"364","author":"Ohnari","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2020.102265_bib0029","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12974-016-0720-6","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients","volume":"13","author":"Pache","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.msard.2020.102265_bib0030","doi-asserted-by":"crossref","first-page":"470\u2010482","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2020.102265_bib0031","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1212\/WNL.0000000000008684","article-title":"Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders","volume":"94","author":"Ringelstein","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2020.102265_bib0032","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/1352458513503053","article-title":"Visual evoked potentials in neuromyelitis optica and its spectrum disorders","volume":"20","author":"Ringelstein","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2020.102265_bib0033","first-page":"11","article-title":"The use of AQP4-antibody testing in diagnosis Thai patients with neuromyelitis optica","volume":"19","author":"Sasitorn","year":"2014","journal-title":"Neurol. Asia"},{"key":"10.1016\/j.msard.2020.102265_bib0034","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.msard.2016.11.008","article-title":"Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders","volume":"11","author":"Schmidt","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2020.102265_bib0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ophtha.2018.06.022","article-title":"Differing structural and functional patterns of optic nerve damage in multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"126","author":"Shen","year":"2019","journal-title":"Ophthalmology"},{"issue":"1\u20132","key":"10.1016\/j.msard.2020.102265_bib0036","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jns.2014.03.033","article-title":"Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: a comparison with seropositive cases","volume":"341","author":"Siritho","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2020.102265_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170847","article-title":"Retinal nerve fiber layer may be better preserved in MOG-IgG versus AQP4-IgG optic neuritis: a cohort study","volume":"12","author":"Stiebel-Kalish","year":"2017","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.msard.2020.102265_bib0037","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.0b013e31822c61b1","article-title":"AQP4 antibody-positive Thai cases: clinical features and diagnostic problems","volume":"77","author":"Siritho","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102265_bib0039","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1172\/JCI122942","article-title":"Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica","volume":"129","author":"Soltys","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.msard.2020.102265_bib0040","article-title":"Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning [published online ahead of print, 2019 Jul 31]","author":"Sotirchos","year":"2019","journal-title":"Mult. Scler."},{"issue":"Pt 5","key":"10.1016\/j.msard.2020.102265_bib0041","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2020.102265_bib0042","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1038\/s41598-019-46251-3","article-title":"In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis","volume":"9","author":"Vabanesi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2020.102265_bib0043","article-title":"The frequency of anti-aquaporin-4 Ig g antibody in neuromyelitis optica and its spectrum disorders at a single tertiary referral center in malaysia","volume":"2014","author":"Viswanathan","year":"2014","journal-title":"Mult. Scler. Int."},{"issue":"1\u20132","key":"10.1016\/j.msard.2020.102265_bib0044","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2009.02.371","article-title":"Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients","volume":"281","author":"Watanabe","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2020.102265_bib0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2020.102265_bib0046","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102265_bib0047","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jchemneu.2019.01.012","article-title":"Visual impairment in neuromyelitis optica spectrum disorders (NMOSD)","volume":"97","author":"Wu","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.msard.2020.102265_bib0048","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1212\/NXI.0000000000000110","article-title":"Aquaporin-4 autoimmunity","volume":"2","author":"Zekeridou","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820303412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820303412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:49:43Z","timestamp":1761900583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820303412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":45,"alternative-id":["S2211034820303412"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102265","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between aquaporin-4 antibody status and visual tract integrity in neuromyelitis optica spectrum disorders: A visual evoked potential study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102265"}}